Video interview with patient with childhood asthma and ABPA, who showed a marked improvement in her ABPA and asthma when she commenced nebulised Amphotericin B. Her medication was changed from itraconazole at this time to allow for her to try for pregnancy. Two types of nebuliser – VentStream and the Pari LC system are discussed in the interview. Her condition is still stable using inhaled amphotericin B. We thank the patient for kindly providing this interview
Share this post
Latest News posts
World Aspergillosis Day 2020
February 3, 2020
Hope on the horizon: Novel antifungal treatments in development
January 20, 2020
How can I protect myself from air pollution?
January 17, 2020
‘Smart shirt’ used to monitor lung function
December 4, 2019
Bedding, allergies and lung health
December 2, 2019
The importance of measles vaccination
November 8, 2019
Fireworks, bonfires and aspergillosis
November 6, 2019
How people with aspergillosis can help look after their liver
October 28, 2019
A step-change in computer power for aspergillosis genomics
October 24, 2019
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video